TÜRKİYE KALP YETMEZLİĞİ MORTALİTE TRENDİ, 2009-2019

Giriş: Kalp yetmezliği, koroner arter hastalığı ve inmeden sonra en sık üçüncü ölüm nedenidir. Bu denli mortalitesi yüksek bir hastalığı kontrol altına alabilmek için öncelikle ölüm oranlarını bilmek gerekir. Biz çalışmamızda Türkiye'de son on yılda kalp yetmezliğine bağlı ölümlerin verilerini alarak bir mortalite trendi oluşturmayı hedefledik. Yöntemler: Türkiye için nüfus tahminlerini TÜİK web sitesinden elde ettik. Yaşa ve cinsiyete özel ve yaşa göre standardize edilmiş oranlar (Dünya standart popülasyonu ve doğrudan standardizasyon yöntemi kullanılarak ASR'ler) hesaplandı. Kalp yetmezliğinden ölüm eğilimleri Joinpoint regresyon analizi kullanılarak değerlendirildi. İstatistiksel analiz, Joinpoint yazılımı 4.9.0.0 sürümü ile gerçekleştirildi. 0,05'ten küçük p değerleri istatistiksel olarak anlamlı kabul edildi Bulgular: Türkiye'nin 10 yıllık standardize ölüm oranını %20.63 olarak bulduk. En yüksek ölüm oranı batı Marmara'da; en düşük oran Doğu Karadeniz’dedir. Toplam popülasyonda 10 yılda mortalitede önemli bir artış gözlemledik(p:0,008). 2009-2016 yılları arasında önemli bir artış (p< 0.001) ve 2016 sonrası önemli bir düşüş (p:0.047) tespit ettik. Sonuç: 2009-2019 yılları arasında Türkiye'deki kalp yetmezliği hastalarının yaş, cinsiyet ve yıllara göre standartlaştırılmış ölüm hızlarını elde ettik. 2016'dan sonra kalp yetmezliğinin genel mortalite düşme eğilimindedir. Anahtar Kelimeler: Kalp Yetmezliği, Türkiye, Mortalite

Anahtar Kelimeler:

Kalp Yetmezliği, Türkiye, Mortalite

TRENDS IN BURDEN OF HEART FAILURE MORTALITY IN TURKEY, 2009-2019

Introduction: Heart failure is the third most common cause of death after coronary artery disease and stroke. If we monitor the mortality of such a fatal disease, we can control the disease more in our study. Therefore, we aimed to create a mortality trend by taking the data of deaths due to heart failure in Turkiye in the last ten years. Methods: We obtained population estimates for Turkey from the TurkStat website. Age- and sex-specific and age-standardized rates (ASRs, using the World standard population and the method of direct standardization) were calculated. Mortality trends from heart failure were assessed using the Joinpoint regression analysis. Statistical analysis was carried out with the Joinpoint software, version 4.9.0.0. We considered p values less than 0.05 to be statistically significant. Results: We found Turkey's 10-year standardized mortality rate is 20.63%. The highest mortality rate is in the western Marmara; the lowest one is Eastern Karadeniz. We observed a significant increase in mortality at 10 years in the total population.(p:0,008). We detected a significant growth between 2009 and 2016 (p< 0.001) and a significant decrease after 2016 (p:0.047) Conclusion: We obtained standardized mortality rates of heart failure patients in Turkey between 2009 and 2019 according to age, sex and years. We showed the overall mortality reduction after 2016.

Keywords:

Heart failure, Turkiye, Mortality,

PDF

___

1. Yilmaz MB, Çelik A, Çavusoglu Y, Bekar L, Onrat E, et al. Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR. Turk Kardiyol Dern Ars 2019; 47: 198–206. doi:10.5543/TKDA.2019.66877
2. Değertekin M, Erol C, Ergene O, Tokgözoğlu L, Aksoy M, Erol MK, et al. Heart failure prevalence and predictors in Turkey: HAPPY study. Turk Kardiyol Dern Ars 2012; 40: 298-308.
3. Yılmaz MB, Aksakal E, Aksu U, Altay H, Yıldırım N, Çelik A, et al. Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality. Anatol J Cardiol 2020; 23:160–8. doi:10.14744/AnatolJCardiol.2019.87894
4. Türkiye İstatistik Kurumu (TÜİK) [Internet].. Available from: https://www.tuik.gov.tr/
5. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: World Health Organization 2001; 9.
6. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
7. Kim HJ, Luo J, Chen HS, Green D, Buckman D, Byrne J, et al. Improved confidence interval for average annual percent change in trend analysis. Stat Med 2017; 36: 3059–74. doi:10.1002/SIM.7344
8. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670–82. doi:10.1002/SIM.3733
9. Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics 2004; 60: 1005–14. doi:10.1111/J.0006-341X.2004.00256.X
10. Ziaeian B, Fonarow GC. Epidemiology and etiology of heart failure. Nat Rev Cardiol 2016; 13: 368–78. doi:10.1038/NRCARDIO.2016.25
11. Akintoye E, Briasoulis A, Egbe A, Dunlay SM, Kushwaha S, Levine D, et al. National Trends in Admission and In‐Hospital Mortality of Patients With Heart Failure in the United States (2001–2014). J Am Hear Assoc Cardiovasc Cerebrovasc Dis 2017; 6. doi:10.1161/JAHA.117.006955
12. Members WC, Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article. Circulation 2005;112: 1825–52. doi:10.1161/CIRCULATIONAHA.105.167587
13. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries. J Am Hear Assoc Cardiovasc Cerebrovasc Dis 2018;7. doi:10.1161/JAHA.118.008687
14. Schmidt M, Ulrichsen SP, Pedersen L, Bøtker HE, Sørensen HT. Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study. Eur J Heart Fail; 18: 490–9. doi:10.1002/EJHF.486
15. Barasa A, Schaufelberger M, Lappas G, Swedberg K, Dellborg M, Rosengren A. Editor's choice: Heart failure in young adults: 20-year trends in hospitalization, etiology, and case fatality in Sweden. Eur Heart J 2014; 35: 25. doi:10.1093/EURHEARTJ/EHT278
16. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016; 18: 613–25. doi:10.1002/ejhf.566
17. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in the first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009; 119: 515–23. doi:10.1161/CIRCULATIONAHA.108.812172
18. Mosterd A, Reitsma JB, Grobbee DE. Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? Heart 2002; 87:75-6.
19. Márquez-Calderón S, Pérez Velasco L, Viciana-Fernández F, Fernández Merino JC. Trends in age-sex-specific mortality in Spain (1981-2016). Changes associated with the economic crisis. Gac Sanit 2020; 34: 230–7. doi:10.1016/J.GACETA.2019.03.007
20. Yılmaz MB, Aksakal E, Aksu U, Altay H, Nesligül Y, Çelik A, et al. Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality. Anatol J Cardiol 2020; 23: 160-8. doi:10.5543/tkda.2019.66877
21. Gürsel G, Levent E, Öztürk C, Karalezli A. Hospital based survey of lung cancer in Turkey, a developing country, where smoking is highly prevalent. Lung Cancer 1998; 21: 127-32.
22. Çavuşoğlu Y, Zoghi M, Eren M, Bozçalı E, Kozdağ G, Şentürk T, et al. Post-discharge heart failure monitoring program in Turkey: Hit-PoinT. Anatol J Cardiol 2017; 17:107. doi:10.14744/ANATOLJCARDIOL.2016.6812
23. Ekici B, Yaman M, Küçük M, Dereli S, Yenerçaǧ M, Yiǧit Z, et al. Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR). Turk Kardiyol Dern Ars 2021; 49: 357–67. doi:10.5543/TKDA.2021.63099
24. Işeri A, Arslan N. Obesity in adults in Turkey: age and regional effects. Eur J Public Health. 2009; 19: 91–4. doi:10.1093/EURPUB/CKN107
25. Gök G, Sinan ÜY, Özyüncü N, Zoghi M. The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study ELDER-TÜRK Investigators. Turk Kardiyol Dern Ars 2018; 46: 283–95. doi:10.5543/tkda.2018.49579
26. Tatar M, Mollahaliloglu S, Sahin B. et al. Turkey: health system review.World Health Organization ‎2011‎; 1817-6127: 186.